Oncopeptides AB (ONCO) — Free Cash Flow Generation Index
Latest as of June 2024:
1.00x
Oncopeptides AB (ONCO) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of Skr8.78 Million represents 1% of operating cash flow (Skr8.77 Million). See ONCO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
Skr8.78 Million
SEK
Operating Cash Flow
Skr8.77 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Free Cash Flow Generation for Oncopeptides AB (None–None)
Year-by-year Free Cash Flow Generation Index for Oncopeptides AB. For the full company profile including market capitalisation, see Oncopeptides AB market capitalisation.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).